31 related articles for article (PubMed ID: 36657245)
1. Clinical trials in advanced stage lung cancer: a survey of patients' opinion about their treatment.
Zaric B; Perin B; Ilic A; Kopitovic I; Matijasevic J; Andrijevic L; Secen N; Stanic J; Bijelovic M; Kosjerina Z; Antonic M
Multidiscip Respir Med; 2011 Feb; 6(1):20-7. PubMed ID: 22958587
[TBL] [Abstract][Full Text] [Related]
2. CheckMate 227 trial has not checked the immune-strategy in first-line setting in advanced non-small cell lung cancer.
Remon J; Collazo A; Jimenez B
Transl Cancer Res; 2020 Apr; 9(4):2168-2170. PubMed ID: 35117575
[No Abstract] [Full Text] [Related]
3. Not just a number, the benefit of mixed methods studies: An editorial.
VanderWalde NA
J Geriatr Oncol; 2023 Mar; 14(2):101409. PubMed ID: 36522276
[No Abstract] [Full Text] [Related]
4. Exploring the Efficacy of Pembrolizumab in Combination with Carboplatin and Weekly Paclitaxel for Frail Patients with Advanced Non-Small-Cell Lung Cancer: A Key Investigative Study.
Thomas QD; Chaabouni M; Al Herk A; Lefevbre C; Cavaillon S; Sinoquet L; Pouderoux S; Viala M; Roca L; Quantin X
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473356
[TBL] [Abstract][Full Text] [Related]
5. Enrollment of older metastatic breast cancer patients in first-line clinical trials: 9-year experience of the large-scale real-life multicenter French ESME cohort.
Bringuier M; Carton M; Levy C; Patsouris A; Pasquier D; Debled M; Rigal O; Jacot W; Gonçalves A; Desmoulins I; De La Motte Rouge T; Bachelot T; Ferrero JM; Eymard JC; Ung M; Mouret-Reynier MA; Petit T; Chevrot M; Uwer L; Courtinard C; Frenel JS; Vianzone A; Baldini C
Breast Cancer Res Treat; 2022 Feb; 191(3):577-587. PubMed ID: 34984582
[TBL] [Abstract][Full Text] [Related]
6. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer (NEJ026): overall survival analysis of an open-label, randomised, multicentre, phase 3 trial.
Kawashima Y; Fukuhara T; Saito H; Furuya N; Watanabe K; Sugawara S; Iwasawa S; Tsunezuka Y; Yamaguchi O; Okada M; Yoshimori K; Nakachi I; Seike M; Azuma K; Kurimoto F; Tsubata Y; Fujita Y; Nagashima H; Asai G; Watanabe S; Miyazaki M; Hagiwara K; Nukiwa T; Morita S; Kobayashi K; Maemondo M
Lancet Respir Med; 2022 Jan; 10(1):72-82. PubMed ID: 34454653
[TBL] [Abstract][Full Text] [Related]
8. IFCT-1502 CLINIVO: real-world evidence of long-term survival with nivolumab in a nationwide cohort of patients with advanced non-small-cell lung cancer.
Molinier O; Besse B; Barlesi F; Audigier-Valette C; Friard S; Monnet I; Jeannin G; Mazières J; Cadranel J; Hureaux J; Hilgers W; Quoix E; Coudert B; Moro-Sibilot D; Fauchon E; Westeel V; Brun P; Langlais A; Morin F; Souquet PJ; Girard N
ESMO Open; 2022 Feb; 7(1):100353. PubMed ID: 34953398
[TBL] [Abstract][Full Text] [Related]
9. Enrolment of older adults with advanced or metastatic non-small cell lung cancer in first-line clinical trials in the multicentre ESME cohort.
Bringuier M; Carton M; Debieuvre D; Pasquier D; Perol M; Filleron T; Léna H; Quantin X; Simon G; Baldini C
J Geriatr Oncol; 2023 Mar; 14(2):101423. PubMed ID: 36657245
[TBL] [Abstract][Full Text] [Related]
10. Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation.
Brown T; Pilkington G; Bagust A; Boland A; Oyee J; Tudur-Smith C; Blundell M; Lai M; Martin Saborido C; Greenhalgh J; Dundar Y; Dickson R
Health Technol Assess; 2013 Jul; 17(31):1-278. PubMed ID: 23886301
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials.
Khan M; Lin J; Liao G; Tian Y; Liang Y; Li R; Liu M; Yuan Y
Medicine (Baltimore); 2018 Aug; 97(33):e11936. PubMed ID: 30113497
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
